Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JAB-30355 |
Trade Name | |
Synonyms | JAB 30355|JAB30355 |
Drug Descriptions |
JAB-30355 is a selective TP53 Y220C reactivator, which increases expression of TP53 target genes and potentially decreases tumor cell viability and inhibits growth of tumors harboring TP53 Y220C (Cancer Res (2024) 84 (6_Supplement): 5940). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JAB-30355 | JAB-30355 | 0 | 1 |